• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于缝线的血管闭合术与大口径动脉切开术的手术闭合:真实世界经验

Suture-Based Vascular Closure Versus Surgical Closure of Large Bore Arteriotomies: A Real-World Experience.

作者信息

Murthy Keshava, Kumar J Ratheesh, Kaur Navjyot, Chadha Amitoj, Chauhan Rajeev, Chadha Davinder

机构信息

Cardiology Department, Army Hospital Research and Referral, New Delhi, IND.

Cardiology Department, Command Hospital Air Force, Bengaluru, IND.

出版信息

Cureus. 2024 Feb 25;16(2):e54856. doi: 10.7759/cureus.54856. eCollection 2024 Feb.

DOI:10.7759/cureus.54856
PMID:38533167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10964123/
Abstract

INTRODUCTION

With the introduction of transcatheter aortic valve implantation (TAVI), endovascular abdominal aortic aneurysm repair (EVAR), thoracic endovascular aortic aneurysm repair (TEVAR), and frequent use of left ventricular assist devices in complicated percutaneous coronary interventions, the use of large bore arterial access has become a necessity. In the index study, we compared the percutaneous closure of large arteriotomies with open surgical (OS) closure.

METHODS

It was a prospective study in which we compared the technical success and vascular complication rate associated with the use of a suture-based vascular closure device (VCD): Perclose ProGlide (PP) with that of OS closure. The study was carried out at Command Hospital Air Force, Bengaluru, India, from January 1, 2016, to December 31, 2020. The inclusion criteria were any percutaneous intervention involving large bore arterial access (≥12 French (F) sheath). The exclusion criteria were any condition where a persistent need for vascular access at the end of the procedure was required. We noted the baseline characteristics and type of anesthesia for all patients. The primary outcome was technical success and major vascular complications, which included major local site bleeding: Bleeding Academic Research Consortium (BARC) 3 or more, failed hemostasis requiring a second intervention, and acute vessel occlusion. Total time taken for the procedure (TTP), time to ambulation (TTA), and time to discharge post-procedure (TTD) were noted for each patient. The secondary outcomes were any bleeding other than major, local hematoma sized >5 cm at 24 hours, pseudo aneurysm formation at 30 days, and acute limb ischemia at 30 days.

RESULTS

A total of 120 patients (PP: 60 (males: 54, females: 6), OS: 60 (males: 50, females: 10)) were included in this study. The mean age of patients was comparable in both groups (PP: 71.8 ± 9.62 years and OS: 71.0 ± 7.76 years, p-value: 0.63). Total large arteriotomies (mean size: 18.03F ± 3.34) closed were 184 (PP: 90, OS: 94). The procedures performed were EVAR: 64 (PP: 30, OS: 34), TAVI: 38 (PP: 21, OS: 17), and TEVAR: 18 (PP: 9, OS: 9). All patients in PP group received dual ProGlide with preclose technique. All TEVAR procedures (total arteriotomies: 18) required a vascular sheath of ≥ 24F. There was no statistical difference between the mean size of sheaths used in the two groups. The technical success (PP: 95.55%, OS: 97.87%, 95% CI: -5.78%-10.98%, p-value: 0.48) and rate of major complications were similar in both groups. Three patients in the PP group who had failed hemostasis with two ProGlides were successfully managed with one additional Angioseal (6F) each. The occurrence of hematoma sized larger than 5 cm was significantly more in the PP group compared to the OS group (PP: 7 (7.78%), OS: 0 (0%), p-value: 0.006). While GA was used for all patients who underwent vascular closure with OS, only eight patients (13.33%) in the PP group required GA. The TTP, TTA, and TTD were significantly lower in the PP group as compared to the OS group.

CONCLUSION

The percutaneous closure of large bore arteriotomies with suture-based VCDs is equally effective and is not associated with increased major vascular complications. In fact, the TTP, TTA, and TTD are significantly lower in the PP group which can translate to better patient comfort and lower costs.

摘要

引言

随着经导管主动脉瓣植入术(TAVI)、血管腔内腹主动脉瘤修复术(EVAR)、胸主动脉腔内修复术(TEVAR)的引入,以及在复杂经皮冠状动脉介入治疗中频繁使用左心室辅助装置,大口径动脉通路的使用已成为必要。在本研究中,我们比较了经皮闭合大动脉切开术与开放手术(OS)闭合的效果。

方法

这是一项前瞻性研究,我们比较了使用基于缝线的血管闭合装置(VCD):Perclose ProGlide(PP)与开放手术闭合的技术成功率和血管并发症发生率。该研究于2016年1月1日至2020年12月31日在印度班加罗尔的空军司令部医院进行。纳入标准为任何涉及大口径动脉通路(≥12法国(F)鞘)的经皮介入治疗。排除标准为术后持续需要血管通路的任何情况。我们记录了所有患者的基线特征和麻醉类型。主要结局是技术成功率和主要血管并发症,包括主要局部部位出血:出血学术研究联盟(BARC)3级或更高、止血失败需要二次干预以及急性血管闭塞。记录每位患者的手术总时间(TTP)、下床活动时间(TTA)和术后出院时间(TTD)。次要结局是除主要出血外的任何出血、24小时时局部血肿大小>5 cm、30天时假性动脉瘤形成以及30天时急性肢体缺血。

结果

本研究共纳入120例患者(PP组:60例(男性:54例,女性:6例),OS组:60例(男性:50例,女性:10例))。两组患者的平均年龄相当(PP组:71.8±9.62岁,OS组:71.0±7.76岁,p值:0.63)。共闭合184处大动脉切开术(平均大小:18.03F±3.34)(PP组:90处,OS组:94处)。所进行的手术包括EVAR:64例(PP组:30例,OS组:34例)、TAVI:38例(PP组:21例,OS组:17例)和TEVAR:18例(PP组:9例,OS组:9例)。PP组所有患者均采用双ProGlide预闭合技术。所有TEVAR手术(共18处动脉切开术)均需要≥24F的血管鞘。两组使用的鞘的平均大小无统计学差异。两组的技术成功率(PP组:95.55%,OS组:97.87%,95%CI:-5.78%-10.98%,p值:0.48)和主要并发症发生率相似。PP组中有3例患者使用两个ProGlide止血失败,分别通过额外使用一个Angioseal(6F)成功处理。与OS组相比,PP组中血肿大小大于5 cm的发生率显著更高(PP组:7例(7.78%),OS组:0例(0%),p值:0.006)。虽然所有接受OS血管闭合的患者均使用全身麻醉(GA),但PP组中只有8例患者(13.33%)需要GA。与OS组相比,PP组的TTP、TTA和TTD显著更低。

结论

使用基于缝线的VCD经皮闭合大口径动脉切开术同样有效,且不会增加主要血管并发症。事实上,PP组的TTP、TTA和TTD显著更低,这可以转化为更好的患者舒适度和更低的成本。

相似文献

1
Suture-Based Vascular Closure Versus Surgical Closure of Large Bore Arteriotomies: A Real-World Experience.基于缝线的血管闭合术与大口径动脉切开术的手术闭合:真实世界经验
Cureus. 2024 Feb 25;16(2):e54856. doi: 10.7759/cureus.54856. eCollection 2024 Feb.
2
Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.使用 MANTA 和 Perclose 进行经导管主动脉瓣置换术大口径入路闭合的倾向评分匹配比较:真实世界经验。
Catheter Cardiovasc Interv. 2021 Sep;98(3):580-585. doi: 10.1002/ccd.29786. Epub 2021 May 29.
3
Total percutaneous access for endovascular aortic aneurysm repair ("Preclose" technique).血管腔内主动脉瘤修复术的全经皮入路(“预闭合”技术)
J Vasc Surg. 2007 Jun;45(6):1095-101. doi: 10.1016/j.jvs.2007.01.050. Epub 2007 Mar 29.
4
Outcomes of routine use of percutaneous access with large-bore introducer sheaths (>21F outer diameter) during endovascular aneurysm repair.在血管内动脉瘤修复期间常规使用大口径引入鞘(外径>21F)进行经皮入路的结果。
J Vasc Surg. 2021 Jan;73(1):81-91. doi: 10.1016/j.jvs.2020.04.504. Epub 2020 May 19.
5
Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.评估 MANTA 经皮血管闭合装置安全性和有效性的关键临床研究。
Circ Cardiovasc Interv. 2019 Jul;12(7):e007258. doi: 10.1161/CIRCINTERVENTIONS.119.007258. Epub 2019 Jul 12.
6
Comparison of percutaneous closure systems for large bore vascular access sites in endovascular procedures.血管内手术中用于大口径血管穿刺部位的经皮闭合系统的比较。
Front Cardiovasc Med. 2023 Apr 5;10:1130627. doi: 10.3389/fcvm.2023.1130627. eCollection 2023.
7
Two-Device Closure Method for Large Diameter Arteriotomies in Percutaneous Endovascular Aortic Repair.经皮血管内主动脉修复术中大直径动脉切口的双器械闭合方法
Ann Vasc Surg. 2020 Jan;62:191-194. doi: 10.1016/j.avsg.2019.06.008. Epub 2019 Aug 23.
8
'Post-Close' Femoral Arterial Haemostasis at Endovascular Aneurysm Repair using a Dedicated Large-Bore Vascular Closure Device: A Prospective Real-World Audit.使用专用大口径血管闭合装置在行血管内动脉瘤修复术后进行股动脉止血的前瞻性真实世界审计。
Cardiovasc Intervent Radiol. 2023 Jul;46(7):835-843. doi: 10.1007/s00270-023-03437-7. Epub 2023 Apr 13.
9
Access site complications in thoracic endovascular aortic repair.胸主动脉腔内修复术中的入路部位并发症
J Vasc Surg. 2024 Apr;79(4):740-747.e2. doi: 10.1016/j.jvs.2023.11.046. Epub 2023 Dec 5.
10
Collagen-Based Vascular Closure Device Multicenter Italian Experience in Endovascular Aortic Aneurysm Repair Compared With Suture-Mediated Closure Vascular Device.基于胶原蛋白的血管闭合装置在血管内主动脉瘤修复中的多中心意大利经验:与缝线介导的闭合血管装置对比
J Endovasc Ther. 2024 Sep 17:15266028241275804. doi: 10.1177/15266028241275804.

引用本文的文献

1
On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications.关于静脉-动脉体外膜肺氧合术后使用MANTA血管闭合装置:有效性及并发症
World J Cardiol. 2025 Mar 26;17(3):101768. doi: 10.4330/wjc.v17.i3.101768.

本文引用的文献

1
Economic Impact And SafetY of Same-Day Discharge Following Percutaneous Coronary Intervention: A Tertiary-Care Centre Experience From Northern India (EASY-SDD).经皮冠状动脉介入治疗后当天出院的经济影响和安全性:来自印度北部的一家三级保健中心的经验(EASY-SDD)。
Cardiovasc Revasc Med. 2022 Jul;40:71-77. doi: 10.1016/j.carrev.2021.11.005. Epub 2021 Nov 8.
2
Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.使用 MANTA 和 Perclose 进行经导管主动脉瓣置换术大口径入路闭合的倾向评分匹配比较:真实世界经验。
Catheter Cardiovasc Interv. 2021 Sep;98(3):580-585. doi: 10.1002/ccd.29786. Epub 2021 May 29.
3
Real-world experience of suture-based closure devices: Insights from the FDA Manufacturer and User Facility Device Experience.基于缝合的闭合装置的真实世界经验:来自 FDA 制造商和用户设施设备经验的见解。
Catheter Cardiovasc Interv. 2021 Sep;98(3):572-577. doi: 10.1002/ccd.29501. Epub 2021 Feb 4.
4
Suture- or Plug-Based Large-Bore Arteriotomy Closure: A Pilot Randomized Controlled Trial.缝线或塞子式大口径动脉切开术闭合:一项先导随机对照试验。
JACC Cardiovasc Interv. 2021 Jan 25;14(2):149-157. doi: 10.1016/j.jcin.2020.09.052. Epub 2020 Dec 23.
5
Large arteriotomies closure using a combination of vascular closure devices during TEVAR/EVAR: A single centre experience.使用血管闭合装置对 TEVAR/EVAR 术中的大血管切口进行闭合:单中心经验。
Indian Heart J. 2020 Jul-Aug;72(4):293-295. doi: 10.1016/j.ihj.2020.06.008. Epub 2020 Jun 30.
6
Cumulative sum analysis of the learning curve for the preclosure technique using Proglide.使用Proglide进行预闭合技术学习曲线的累积和分析。
Interact Cardiovasc Thorac Surg. 2020 Feb 1;30(2):280-286. doi: 10.1093/icvts/ivz257.
7
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
8
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.经导管主动脉瓣置换术治疗低危患者的自膨式瓣膜。
N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.
9
A new Percutaneous technique for effective vascular Access Site closure in patients undergoing Transfemoral aortic valve implantation and thoraco-abdominal aortic aneurysm rEpair: the PASTE study.经股主动脉瓣置换术和胸腹主动脉瘤修复术患者采用经皮有效血管入路封堵的新方法:PASTE 研究。
EuroIntervention. 2018 Dec 20;14(12):e1278-e1285. doi: 10.4244/EIJ-D-18-00245.
10
Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.经导管主动脉瓣置换术后应用 MANTA 与 ProGlide 血管闭合装置的倾向性匹配比较。
EuroIntervention. 2019 Feb 8;14(15):e1558-e1565. doi: 10.4244/EIJ-D-18-00769.